Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-marketing Surveillance of Donepezil Hydrochloride- Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease

NCT01251718 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.

NCT NCT01251718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01251718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-marketing Surveillance of Donepezil Hydrochloride- Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease
Lead sponsor
Eisai Co., Ltd.
Phase
Observational
Overall status
Completed
Start date
December 1, 2010
Completion date
February 18, 2016
Enrollment
894 (actual)
Sites
106

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease